Amalgam Rx
PrivateLast Round
Debt
Aug 12, 2025
Total Funding Raised
$46.65M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Amalgam Rx operates in Healthcare & Life Sciences and is based in Wilmington, Delaware. Its latest recorded funding round was a Debt round in August 2025.
Amalgam Rx is a digital health company that provides a modular platform with EHR-integrated clinical decision support and medical-grade AI to connect healthcare providers and life sciences companies for chronic disease management.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, EHR & EMR, Medical AI
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amalgam Rx Comparables
Compare Amalgam Rx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrightInsight | 87% | |
| Adhera Health | 86% | |
| Sidekick Health | 83% |
For institutional investors. Book with your work email.
Amalgam Rx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Aug 12, 2025 | ||||
| Series B | Oct 5, 2023 | ||||
| Series A | Dec 19, 2022 | ||||
| Series A | Sep 25, 2019 | ||||
| Seed | May 2, 2019 | ||||
VC Round | Jun 20, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Amalgam Rx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalio Capital Management | Debt |
| CVS Health Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 54% MoM.
- Aug 12, 2025
$20M debt round completed.
For institutional investors. Book with your work email.
Amalgam Rx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amalgam Rx's valuation, stock price, and market status.
Is Amalgam Rx a public or private company?
Amalgam Rx is a private company.
What is the current stock price of Amalgam Rx?
Amalgam Rx is a private company, so its shares have no public market price. Caplight tracks Amalgam Rx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amalgam Rx worth (valuation)?
Valuation information for Amalgam Rx is not publicly available.
Can I buy Amalgam Rx stock?
Amalgam Rx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amalgam Rx's last funding round?
Amalgam Rx's most recent funding round was Debt on August 12, 2025.
Who are the main investors in Amalgam Rx?
Key investors in Amalgam Rx include Catalio Capital Management, CVS Health Ventures.
Will Amalgam Rx IPO soon?
No public IPO plans have been announced for Amalgam Rx.
How can I track Amalgam Rx secondary market activity?
Caplight tracks bids, offers, and trades in Amalgam Rx's shares on secondary markets.